Literature DB >> 16581251

The preponderance of P450s in the Mycobacterium tuberculosis genome.

Kirsty J McLean1, Daniel Clift, D Geraint Lewis, Muna Sabri, Philip R Balding, Michael J Sutcliffe, David Leys, Andrew W Munro.   

Abstract

The genome of Mycobacterium tuberculosis (Mtb) encodes 20 different cytochrome P450 enzymes (P450s). P450s are mono-oxygenases, which are historically considered to facilitate prokaryotic usage of unusual carbon sources. However, their preponderance in Mtb strongly indicates crucial physiological functions, as does the fact that polycyclic azoles (known P450 inhibitors) have potent anti-mycobacterial effects. Recent structural and enzyme characterization data reveal novel features for at least two Mtb P450s (CYP121 and CYP51). Genome analysis, knockout studies and structural comparisons signify important roles in cell biology and pathogenesis for various P450s and redox partner enzymes in Mtb. Elucidation of structure, function and metabolic roles will be essential in targeting the P450s as an 'Achilles heel' in this major human pathogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581251     DOI: 10.1016/j.tim.2006.03.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  21 in total

Review 1.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

2.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

3.  Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters.

Authors:  Laura Pérez-Lago; Marta Herranz; Miguel Martínez Lirola; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Authors:  Kirsty J McLean; Paul Carroll; D Geraint Lewis; Adrian J Dunford; Harriet E Seward; Rajasekhar Neeli; Myles R Cheesman; Laurent Marsollier; Philip Douglas; W Ewen Smith; Ida Rosenkrands; Stewart T Cole; David Leys; Tanya Parish; Andrew W Munro
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

5.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

6.  Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1.

Authors:  Kamila Z Rosłoniec; Maarten H Wilbrink; Jenna K Capyk; William W Mohn; Martin Ostendorf; Robert van der Geize; Lubbert Dijkhuizen; Lindsay D Eltis
Journal:  Mol Microbiol       Date:  2009-10-15       Impact factor: 3.501

7.  Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.

Authors:  Pascal Belin; Marie Hélène Le Du; Alistair Fielding; Olivier Lequin; Mickaël Jacquet; Jean-Baptiste Charbonnier; Alain Lecoq; Robert Thai; Marie Courçon; Cédric Masson; Christophe Dugave; Roger Genet; Jean-Luc Pernodet; Muriel Gondry
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-22       Impact factor: 11.205

8.  Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.

Authors:  Max D Driscoll; Kirsty J McLean; Colin Levy; Natalia Mast; Irina A Pikuleva; Pierre Lafite; Stephen E J Rigby; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

Review 9.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

10.  Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.

Authors:  Madeline E Kavanagh; Anthony G Coyne; Kirsty J McLean; Guy G James; Colin W Levy; Leonardo B Marino; Luiz Pedro S de Carvalho; Daniel S H Chan; Sean A Hudson; Sachin Surade; David Leys; Andrew W Munro; Chris Abell
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.